December 2004 PMID 15316165

An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.

Ercan Arca, Gürol Açikgöz, Halis Bülent Taştan, Osman Köse, Zafer Kurumlu

Mentions

9
Peak: 2 in May 2022
across 3 sources since May 2022

Extended reach

191,932
potential audience

Total likes

3,833

Video views

191,459

Mentions per month

May 2022 – Apr 2025

Where it's discussed

  • News5 articles
  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

The collective discussion includes skeptical remarks like 'Sell your product, but not by befooling people,' indicating distrust or critique of marketing tactics, and a question about why finasteride isn’t a more affordable, scientifically-supported choice, showing curiosity but limited engagement with the study’s detailed results. The tone and brevity of comments reflect a superficial engagement with the article's scientific importance.

AgreementLow agreement

The comments express skepticism toward the claims of the publication, with one criticizing the product marketing and another questioning why finasteride isn't more widely chosen for its cost-effectiveness.

InterestModerate interest

The discussions show some interest in the topic of hair loss treatment options but are limited in depth or enthusiasm.

EngagementNeutral engagement

The comments are brief and somewhat dismissive, reflecting minimal in-depth discussion or exploration of the study’s findings.

ImpactLow impact

The discussions seem to have little influence on perception or practice, mostly raising doubts or sharing opinions rather than core scientific insights.

Abstract in brief

  • The study compares the effectiveness of oral finasteride and topical minoxidil over 12 months in treating male androgenetic alopecia, finding that both treatments improved hair growth with no significant differences in patient characteristics.
  • Clinical cure rates were higher with finasteride (80%) compared to minoxidil (52%), and side effects were mild in both groups, primarily involving sexual function and scalp irritation, which resolved after stopping the treatments.
  • Laboratory tests showed no major adverse changes, except for hormonal shifts in the finasteride group, indicating both drugs are generally safe and effective options for male hair loss management.]

Top posts

Most liked on X and Bluesky
Dr.Harman, MD
@drharman15 · X

@kiierrhairgrow Sell your product, but not by befooling people

Apr 1, 2025 · 278 followers View post →
lechef
@lechefish · X

@litesomkafka Varför inte välja det vetenskapligt bättre alternativet finasterid för en bråkdel av priset på recept? https://t.co/1YVqdauzsl ?? Ba dela en vanlig för lågdos ju

May 27, 2022 · 196 followers View post →

All mentions

Dr.Harman, MD
@drharman15 · X

@kiierrhairgrow Sell your product, but not by befooling people

Apr 1, 2025 · 278 followers View post →
lechef
@lechefish · X

@litesomkafka Varför inte välja det vetenskapligt bättre alternativet finasterid för en bråkdel av priset på recept? https://t.co/1YVqdauzsl ?? Ba dela en vanlig för lågdos ju

May 27, 2022 · 196 followers View post →